Citigroup Downgrades QuidelOrtho to Neutral, Lowers Price Target to $72
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Patrick Donnelly has downgraded QuidelOrtho (NASDAQ:QDEL) from Buy to Neutral and reduced the price target from $95 to $72.

December 11, 2023 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
QuidelOrtho's stock rating has been downgraded by Citigroup from Buy to Neutral, with a significant reduction in the price target from $95 to $72.
Analyst downgrades typically lead to a negative short-term reaction in the stock price as they suggest a less favorable outlook for the company. The reduction in the price target further implies a lower expected future stock price, which can also negatively impact investor sentiment.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100